ArticleCancer immunology, immunotherapy : CII2022

Efficacy of immunotherapy beyond RECIST progression in advanced melanoma: a real-world evidence.

Anna Małgorzata Czarnecka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.